Brief: TetraLogic qtrly loss per share $0.53
Feb 26 (Reuters) - TetraLogic Pharmaceuticals Corp TLOG.O : * Reports 2014 financial results and provides clinical programs update * Qtrly loss per share $0.53 * Says expect data from all studies to be available in 2015 * Source text for Eikon ID:nGNXVCWSHa * Further company coverage TLOG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Tetralogic Pharmaceuticals
See all newsNewscasts - Grieving father buries son killed by toxic cough syrup in India
Cellect: Soars on merger deal with Quoin Pharmaceuticals
Brief: Tetralogic announces pacts to restructure convertible debt
Brief: Tetralogic Pharmaceuticals says Pete Meyers resigned as CFO
Brief: TetraLogic Pharmaceuticals says birinapant shows no activity in randomized phase 2 mds study